Although our previous studies have provided evidence for the involvement of the aPKC-ι-Par6 signaling pathway in promoting EMT via the TGF-β1 and Ras signaling axis, our understanding of the mechanisms regulating aPKC-ι expression in HCC tumors is less well characterized. The gene discussed is PARD6A; the disease is hepatocellular carcinoma.